Impression Healthcare recruits Big Pharma executive to complete cannabinoid drug discovery goal

Medical cannabis company Impression Healthcare (ASX: IHL) has continued its top-tier recruitment drive with the addition of yet another pharmaceutical industry expert into its ranks. Former Roche (market cap: US$256 billion) executive John Michailidis has been installed as chief executive officer of Impression’s drug discovery division Incannex, with a key focus of advancing the company’s […]